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Abstract The objective of this study is to evaluate the
effect of exercise on cardiac autonomic function as mea-
sured by short-term heart rate variability (HRV) in females
suffering from rheumatoid arthritis (RA). Females with con-
firmed RA were randomly assigned to an exercise group
(RAE) and a sedentary group (RAC). RAE was required to
train under supervision two to three times per week, for
3 months. Three techniques (time domain, frequency do-
main and Poincaré plot analyses) were used to measure
HRV at baseline and study completion. At baseline, RAC
(n018) had a significantly higher variability compared to
RAE (n019) for most HRV indicators. At study completion,
the variables showing significant changes (p00.01 to 0.05)
favoured RAE in all instances. Wilcoxon signed rank tests
were performed to assess changes within groups from start
to end. RAE showed significant improvement for most of
the standing variables, including measurements of combined
autonomic influence, e.g. SDRR (p00.002) and variables
indicating only vagal influence, e.g. pNN50 (p00.014).
RAC mostly deteriorated with emphasis on variables mea-
suring vagal influence (RMSSD, pNN50, SD1 and HF
(ms2)). Study results indicated that 12 weeks of exercise
intervention had a positive effect on cardiac autonomic
function as measured by short-term HRV, in females with
RA. Several of the standing variables indicated improved
vagal influence on the heart rate. Exercise can thus poten-
tially be used as an instrument to improve cardiac health in a
patient group known for increased cardiac morbidity.
Keywords Autonomic function . Exercise . Heart rate
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Introduction
Rheumatoid arthritis (RA) patients are usually sedentary,
limiting physical activity due to the perceived danger of
eliciting pain or damaging their joints [1]. Although there
is still no cure for RA, much can be done to manage the
condition. There is compelling evidence that exercise can
play a significant role in the physical and psychosocial
health of RA patients [2, 3]. However, only a limited num-
ber of studies exist on the relation of exercise interventions
to cardiovascular disease in these patients [4].
Cardiovascular disease is a well-described entity in RA
patients [5–7]. Conventional risk factors (abnormal body
mass index (BMI), abnormal lipogram, smoking, hyperten-
sion, diabetes mellitus, family history of cardiac disease and
a personal history of cardiac disease) [8, 9], accelerated
atherosclerosis due to inflammation [7, 10, 11], and auto-
nomic dysfunction [12–15] can all play a role in the
etiopathogenesis.
Exercise has been identified as one of the most important
behavioural strategies for cardiovascular disease prevention,
and sedentary individuals (like RA sufferers) will benefit by
just a slight increase in physical activity [16, 17]. Previous
studies in non-RA groups demonstrated that exercise will
improve autonomic function (as measured by heart rate
variability (HRV)) [18–21]. Abnormal autonomic function
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marked by decreased HRV induces an increased dysrhyth-
mogenic potential [22, 23]. An article by Routledge et al. in
2010 reviewed HRV modification via exercise therapy in
patients with clinical conditions [24]. Similar studies have
not been done in the RA population. The aim of the current
study was to evaluate the effect of exercise on cardiac
autonomic function as measured by short-term HRV in RA
patients.
Materials and methods
This study was a randomised experimental design with a
prospective analytical pre-post group comparison. Ethical
approval was granted by the Ethical Committee of the
Faculty of Health Sciences at the University of Pretoria.
Patients in the Pretoria region of South Africa were recruited
from private rheumatology practices and state hospital rheu-
matology clinics.
Patients with RA who conformed to the inclusion and
exclusion criteria were invited to an information and orien-
tation meeting. After which, informed consent was signed
by all participants. Inclusion criteria included that partici-
pants should be females between the age of 30 and 60, with
confirmed RA (according to the 1987 American College of
Rheumatology criteria) [25], class I or II disease (according
to the classification of global functional status in RA) [26],
controlled disease (i.e. on stable evidence-based medication
for at least 3 months and DAS28 scores of low to moderate
activity), and voluntary participation. The exclusion criteria
included smoking, known cardiovascular disease, pulmo-
nary disease, diabetes mellitus, neurological disease, use of
drugs that can interfere with the autonomic nervous system
or the cardiovascular system (anti-hypertensives, anti-
arrhytmic drugs, diuretics, anti-epileptics, vasodilators, ad-
renergic inhibitors, sedatives and hypnotics), liver or kidney
disease and participation in a physical training programme
in the last year.
Colour-coded buttons representing each group (RA con-
trol 0 yellow, RA exercise 0 blue) were put in a non-
transparent bag. Each participant had to draw one of these
colour-coded buttons. The administrator allocated the par-
ticipants into two different groups according to the colour of
the buttons, i.e. an exercise group (RAE) and a control
group (RAC). The RAE group was required to train two to
three times per week, while the RAC group was instructed
to continue with their sedentary lifestyle. The programme
was conducted over 3 months (12 weeks). All exercise
sessions were supervised by a biokineticist (exercise spe-
cialist). Exercise intervention consisted of warm-up exer-
cises, strengthening exercises, aerobic exercises and a cool-
down period which included stretching. The duration of
each session was approximately 45 min.
The warm-up exercise consisted of 5 min of walking,
pool jogging or pool noodle cycling. The aerobic exercise
lasted for 20 min at 60–80 % of peak HR doing either
treadmill walking, water cycling or water jogging. Flexibil-
ity exercise included stretching for each of the major joints
(neck stretch, shoulder rolls, lying hamstring stretch, stand-
ing hip flexor stretch, calf stretches and pectoral stretch).
Five repetitions held for 30 s each were performed. The
strength exercises included chest press, bicep curls, lateral
pull-downs, hip extension, leg presses, hamstring curls and
hip abduction. The intensity and repetitions of these exer-
cises were increased every second week [27, 28].
Measurements for HRV were done at baseline (onset of
the programme) and after 12 weeks (study completion).
HRV is a validated, non-invasive method to study the influ-
ence of the autonomic nervous system (ANS) on the heart.
The parasympathetic and sympathetic nerves act on the
intrinsic rhythm, and this causes beat to beat variations in
the RR interval on the ECG [18, 29, 30].
HRV data sampling
For sampling of the RR-interval data, the participants were
instructed not to train for 48 h before data sampling and to
fast from 2200 hours the previous evening. A low protein
breakfast (cereal with milk only) was permitted on the
morning of testing. No alcohol or caffeine was allowed
during the preceding 24 h. Data was sampled in the morning
in a quiet setting with a room temperature of about 22°C.
Recordings were made over a period of 20 min.
Each participant put on a Polar 810i strap and transmitter
and was then placed in a supine (resting) position for
10 min, breathing spontaneously without talking. This was
followed by a 10-min orthostatic stressor with participants
standing (stress) in an upright position, with their backs
leaning against the wall and their feet apart. RR intervals
from a stationary 5-min resting period and a stationary 5-min
standing period were used for analyses.
HRV quantification
Standard Polar software programs with a minimum beat
protection zone of six beats per minute and a low filter
power were used to remove artefacts in RR-interval data.
The data (RR-interval sets) were analysed using software for
HRV analysis obtained from the University of Kuopio, Fin-
land. Smoothness priors for trend and Model Eye program
settings were used for detrending with an alpha value of
500. The autoregressive model order value was 16, and the
interpolation rate was 4 Hz. The techniques used for the
evaluation of HRV from RR-interval data sets were grouped
into three categories: time domain, frequency domain and
non-linear analysis (Poincarè plot analysis) [29, 31]. As
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there is no gold standard for HRV measurements and no
method has been identified as being superior to another, it
was decided to use all three techniques as they are comple-
mentary to each other [32]. Time domain indicators that
were determined included RR interval (the mean of the inter-
vals between successive QRS complexes) and SDRR (the
standard deviation of intervals between successive QRS com-
plexes) representing vagal and sympathetic influence, i.e. total
variability. RMSSD (root mean square of the standard devia-
tion between RR intervals) and pNN50 (percentage of suc-
cessive RR interval differences larger than 50 ms computed
over the entire recording) representing pure vagal influence on
HRV were also determined [29].
Spectral components analysed with frequency domain
analysis included high frequency (HF00.15–0.40 Hz), low
frequency (LF00.04–0.15 Hz), HF normalised units (nu),
LF (nu) and the LF/HF ratio. The indicators LF/HF, LF (nu)
and HF (nu) were used as indicators of autonomic balance
or relative power distribution between the sympathetic and
parasympathetic branches of the ANS. LF (nu) represents
the relative power of the LF component in proportion to the
total power minus the VLF component. HF (nu) represents
the relative power of the HF component in proportion to the
total power minus the VLF component, while LF/HF is used
to assess the fractional distribution of power [30]. The
Poincarè analysis method produced the indicators SD1 and
SD2. SD1 is an indicator of the standard deviation of the
immediate, or short-term, RR variability due to parasympa-
thetic efferent (vagal) influence on the sino-atrial node. SD2 is
an indicator of the standard deviation of the long-term or slow
variability of the heart rate representing global variation [31].
A summary of the HRV analysis techniques, specific HRV
indicators and origins of variability is explained in Table 1.
Data analysis
Since most of the variables were skewed, non-parametric
tests were conducted. Only two groups (RAE and RAC)
were reported on, hence non-parametric Mann–Whitney U
tests were performed to determine which dependent varia-
bles differed between the two groups. These tests are anal-
ogous to independent samples’ t tests.
Data analysis was also performed within the two groups
(RAE and RAC), comparing pre- and post-intervention meas-
urements. Wilcoxon signed rank tests, which are analogous to
paired sample t tests, were used to determine whether there
was a statistical improvement within each group.
The conventional 5 % level of significance was specified,
and in all instances, the p values of the non-parametric tests
are reported. Effect sizes are reported as a standardised
measure of the observed effect. For the few variables that
did not violate the assumption of normality, a power analy-
sis was also performed.
Results
At study onset, the RAE group consisted of 24 patients, and
the RAC group, of 22. In the RAE group, five (20.83 %) of
the subjects did not complete the study, versus four
Table 1 HRV techniques, HRV indicators and origins of variability
Time domain
analysis
RR (s) The mean of the intervals between successive QRS complexes
Result of vagal and sympathetic influence on HRV
RRSD (s) Standard deviation of intervals between successive QRS complexes
Indicator of vagal and sympathetic influence on HRV (overall HRV)
RMSSD (ms) Root mean square of the standard deviation between RR intervals. Indicator of vagal influence
pNN50 (%) The percentage of successive RR-interval differences larger than 50 ms computed over the entire recording
Indicator of vagal influence on HRV
Poincarè plot
analysis
SD1 (ms) Indicator of the standard deviation of the immediate RR variability due to parasympathetic efferent (vagal)
influence on the sino-atrial node
SD2 (ms) Indicator of the standard deviation of the slow variability of the heart rate. It is accepted that this value is
representative of the global variation in HRV
Frequency
domain analysis
LF (ms2) Indicator of not only sympathetic influence but also a parasympathetic component
HF (ms2) Indicator of only parasympathetic influence
LF/HF Indicator of autonomic balance
LF (nu) LF (normalised units) represents the relative power of the LF component in proportion to the total power
minus the VLF component, i.e. LF / (total power − VLF).
HF (nu) The HF (normalised units) represents the relative power of the HF component in proportion to the
total power minus the VLF component, i.e. HF / (total power − VLF)
LF low frequency, HF high frequency, VLF very low frequency, s seconds, ms milliseconds, % percentage, ms2 milliseconds squared, nu
normalised units
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(18.18 %) in the RAC group. Reasons for not completing
the study included difficulty to conform to time and fre-
quency of training (four from the RAE group), moved to
another town (one from the RAE group), not available for
post-intervention measurements due to other commitments
(two from the RAC group) and loss of interest (two from the
RAC group). Data analyses were only performed on those
subjects who completed the study (RAE group 19, RAC
group 18) because the study focused on the effect of an
exercise intervention and we did not want to bias results by
including subjects not completing the study. This sample
size is similar to the average sample size of clinical studies
that evaluated HRV modification via exercise intervention
[24]. Routledge et al. in 2010 evaluated 19 published
articles, with the average sample size calculated as 21.2
(±10.6).
Information on age, anthropometric data, disease dura-
tion, disease activity, medication used with regard to RA
and presence of auto-antibodies is displayed in Table 2.
Subjects were required to stay on the same medication
regime for the duration of the study, and no intramuscular
or intra-articular corticosteroid injections were allowed.
BMI has previously been reported by some authors as a
confounding factor [33, 34]. From the median test, the
medians of the BMI did not differ significantly between
the two groups (p00.127) although evidence exists that
the distribution of the BMI was not identical across the
two groups (Mann–Whitney U p00.05). Regression models
that included BMI as a covariate did not support the evi-
dence that BMI is a confounder in this study.
The heart rate variability of the two groups was compared
at baseline, and statistics of variables displaying significant
initial bias can be viewed in Table 3. At baseline, the RAC
group had significantly higher heart rate variability com-
pared to the RAE group for some of the supine variables and
most of the standing variables. The RAE group did not show
a significant higher variability than the RAC group for any
variable pre-intervention.
To compensate for the initial bias between the two
groups, the pre-values were subtracted from the post-
values, to assess if the exercise intervention caused changes
that favoured any of the two groups. The variables that
showed significant differences in changes at study comple-
tion are displayed in Table 4. These amounted to medium to
large effects [35] and favoured the RAE group in all
instances.
To evaluate any changes that occurred within each group
from the start of the intervention to the completion,
Table 2 Demographic information on RAE and RAC groups
Variable RAE group (n019) (mean ± SD) RAC group (n018) (mean ± SD) p value
Age (years) 46.81±9.23 47.08±7.05 0.92
Height (m) 1.64±0.07 1.65±0.08 0.69
Weight (kg) 69.9±11.5 80.30±16.18 0.03*
BMI 25.98±3.53 29.52±6.04 0.04*
Disease duration (years) 4.53±0.90 3.98±1.10 0.11
DAS28 3.29±0.72 3.25±1.08 0.73
Resting heart rate (bpm) 80.60±8.2 73.36±7.89 0.01*
RA medication
Prednisonea 10 10




Non-steroidal anti-inflammatory drugsb 18 17
Biologicsc 4 6
Antibodies
Positive rheumatoid factor 17 15
Positive anti-CCP 9 10
SD standard deviation, BMI body mass index, DAS disease activity score, bpm beats per minute, anti-CCP anti-citrullinated peptide antibodies
*p<0.05
aMaximum dose of prednisone allowed was 10 mg per day
b Only therapeutic doses allowed
cMedication made from living organisms which are used as a therapeutic agent, e.g. infliximab, etanercept and adalimumab
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Wilcoxon signed rank tests were performed. The RAE
group showed statistical significant changes for SDRR in
the supine position and for SDRR and pNN50 in the stress
position. The RAC group showed statistical significant
changes for SDRR (supine), SDRR (stress), RMSSD
(stress), pNN50 (stress), SD1 (stress) and LF/HF (stress).
The variables for both groups are displayed in Table 5 and
again amounted to medium to large effects [35]. Although
not statistically significant at the specified 5 % level of
significance, there was moderate evidence (α<0.10) of
change in many variables (RAE group: RR (supine), LF
(nu) (supine), RR (stress), HR (stress), RMSSD (stress),
SD1 (stress), SD2 (stress), LF (ms2) (stress); RAC group:
HF (ms2) (stress), HF (nu) (stress)). Within the RAE group,
the variables mostly improved, contrary to the RAC group
where the change was mostly a deterioration (i.e. less para-
sympathetic activity and an increased sympathetic drive in
the RAC group at study completion).
Discussion
This study demonstrates that exercise intervention has a
positive effect on autonomic function of RA patients, as
measured by short-term heart rate variability. Comparing
the exercise group to the control group at baseline, the
control group showed better heart rate variability. However,
at study completion, this change was in favour of the exer-
cise group who then showed better heart rate variability. Our
results are confirmed by that of Jurca et al. in 2004 who,
after 8 weeks of moderate exercise training in females,
showed improved vagal modulation of heart rate on 10-
min resting ECGs [36].
Many previous studies done on diseased populations to
evaluate the effect of short-term exercise intervention on
short-term HRV modification assessed only supine variables
[37–43]. Sandercock et al. in 2007 observed significant
increases in the supine RR interval, SDRR, LF(ln) and HF
Table 3 Statistics of variables
displaying initial bias
s seconds, bpm beats per minute,
ms milliseconds, % percentage,
ms2 milliseconds squared, nu
normalised units
*p<0.05; **p<0.01
Variable RAE group (median) RAC group (median) p value Group favoured
Supine (resting)
RR (s) 0.76 0.79 0.045* RAC
HR (bpm) 79.17 76.12 0.049* RAC
pNN50 (% ) 0.00 1.70 0.022* RAC
LF power (ms²) 46.00 147.50 0.002** RAC
Stress (standing)
SDRR (s) 0.01 0.02 0.006** RAC
RMSSD (ms) 7.50 19.25 0.002** RAC
pNN50 (%) 0.00 1.20 0.001** RAC
SD1 (ms) 5.40 13.80 0.002** RAC
SD2 (ms) 28.35 57.80 0.001** RAC
LF power (ms²) 38.50 174.50 <0.001** RAC
HF power (ms²) 5.00 38.00 <0.001** RAC
LF (nu) 86.30 73.85 0.042* RAC
LF/HF 7.55 3.68 0.020* RAC
Table 4 Variables that showed
significant differences in
changes (post-value minus pre-
value) between the RAE and
RAC groups after intervention
s seconds, bpm beats per minute,
ms milliseconds, % percentage
*p<0.05; **p<0.01
Variable Differences p value Effect size (power) Group favoured
RAE group RAC group
Supine (resting)
RR (s) 0.07 −0.01 0.022* 0.52 (0.60) RAE
HR (bpm) −6.79 1.47 0.029* 0.49 (0.61) RAE
Stress (standing)
RR (s) 0.03 0.00 0.033* 0.47 RAE
HR (bpm) −6.91 −0.31 0.021* 0.52 RAE
RMSSD (ms) 1.40 −3.90 0.012* 0.59 RAE
pNN50 (%) 0.00 −0.20 0.005** 0.66 RAE
SD1 (ms) 0.90 −2.80 0.011* 0.59 RAE
SD2 (ms) 3.40 −3.40 0.050* 0.42 RAE
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(ln) in a group of patients, who had coronary artery bypass
grafting and angioplasty following myocardial infarction
(MI), after 8 weeks of cardiac rehabilitation [37]. Malfatto
in 1996 also showed significant increases for RR interval,
SDRR, RMSSD, pNN50 and HF but a decline in LF in
patients who followed a training programme after MI [38].
On the other hand, Oya et al. in 1999 could not show any
significant difference in HRV in MI patients after a 3-month
training programme [39]. Figueroa et al. in 2007 observed a
significant increase in LF and HF in a 16-week study in
obese women with and without type 2 diabetes mellitus
[43]. All the above mentioned studies (except that of Oya
et al.) thus showed increased vagal tone (HF, RMSSD,
pNN50), but the LF variable seems to be difficult to inter-
pret with changes in different directions in the different
studies.
In the present study, only the RR interval increased
significantly in the supine position, while the other variables
did not show significant changes in favour of the exercise
group. It is not clear why increased vagal tone was not
picked up in the supine position in our analyses; however,
Iwasaki et al. in 2003 did a study where HF and RR interval
increased early in the training of young previously sedentary
subjects, but at study completion after 1 year, HF regressed
towards initial values whereas RR interval uniformly in-
creased. They suggested that initial increases may be due
to higher vagal modulation, while other factors such as heart
geometry may play a role in further adaptation [44].
It was mainly the variables obtained in the standing
position that were affected favourably in our exercise group
in comparison to the control group. Zoppini et al. in 2007
found similar results in a study on patients with type 2
diabetes mellitus where they showed significant changes in
standing, but not supine variables after a 6-month exercise
programme [45]. In the current study, the changes reflected
a greater effect on increased vagal rather than on decreased
sympathetic influence. Buch et al. in 2002 pointed out that
patients may have a better survival advantage with enhanced
vagal tone. Reasons offered were that greater vagal influ-
ence will decrease heart rate and myocardial contractility
(i.e. due to less workload and oxygen consumption), hinder
sympathetic influence on the sinus node and reduce the risk
of ventricular dysrhythmias [46]. Therefore, improving the
vagal tone in RA patients may be an instrument to decrease
their cardiovascular morbidity and mortality.
De Meersman commented that “Ultimately, all of these
cardiovascular diseases are associated with a common de-
nominator, namely a perturbed autonomic balance. It is
tempting, therefore, to hypothesise that preservation of car-
diac autonomic function by lifestyle or interventions should
be associated with a marked reduction in the risk of cardio-
vascular disease and death” [47]. Exercise intervention
appears to have an advantageous effect on cardiac autonom-
ic function in RA patients as measured by short-term heart
rate variability. Especially, vagal modulation seems to im-
prove, and this can lead to improved cardiac health in a
patient group already suffering from impaired lifestyle due
to joint pain and other complications following a diagnosis
of RA.
Limitations of the study
Unfortunately, this study suffers from the implication of low
statistical power, due to the unavoidable small sample size;
therefore, effect sizes were reported to quantify the effec-
tiveness of the intervention. Similar studies, e.g. on diabetic
[43, 45] and cardiac patients [38, 40, 41], had equal or even
less participants.
Table 5 HRV variables that showed a change from pre- to post-intervention within the RAE and RAC groups
Variable Median pre-value Median post-value p value Effect size (power) I/D
RAE group
Supine (resting) SDRR (s) (0.017a) 0.02 (0.022a) 0.02 0.022* 0.52 I
Stress (standing) SDRR (s) 0.01 0.02 0.002** 0.74 I
pNN50 (%) 0.00 0.00 0.014* 0.57 ~
RAC group
Supine (resting) SDRR (s) 0.02 0.03 0.049* 0.41 (0.30) I
Stress (standing) SDRR (s) 0.02 0.03 0.013* 0.54 (0.83) I
RMSSD (ms) 19.25 13.30 0.038* 0.43 (0.66) D
pNN50 (%) 1.20 0.50 0.035* 0.44 D
SD1 (ms) 13.80 9.60 0.036* 0.44 (0.69) D
LF/HF 3.68 5.82 0.042* 0.42 (0.61) D
s seconds, % percentage, ms milliseconds, I improved on median values, D deterioration on median values
*p<0.05; **p<0.01
a Reflects true value where rounded off value could be misleading
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Heart rate variability was the only tool used to assess the
function of the autonomic nervous system. Including tests
such as analysis of blood pressure variability may add
information and support results obtained by HRV analysis.
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